Opus Genetics, Inc.
IRD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $11 | $19 | $40 | $1 |
| % Growth | -42.3% | -52.2% | 6,665.7% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $11 | $19 | $40 | $1 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $27 | $18 | $14 | $15 |
| G&A Expenses | $18 | $12 | $7 | $8 |
| SG&A Expenses | $18 | $12 | $7 | $8 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $28 | $0 | $0 | $0 |
| Operating Expenses | $73 | $30 | $22 | $23 |
| Operating Income | -$62 | -$11 | $18 | -$23 |
| % Margin | -564.7% | -55.5% | 45.7% | -3,854.8% |
| Other Income/Exp. Net | $5 | $1 | -$0 | -$34 |
| Pre-Tax Income | -$58 | -$10 | $18 | -$57 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$58 | -$10 | $18 | -$57 |
| % Margin | -523.4% | -52.4% | 44.9% | -9,625.3% |
| EPS | -2.15 | -0.46 | 0.9 | -3.82 |
| % Growth | -367.4% | -151.1% | 123.6% | – |
| EPS Diluted | -2.15 | -0.46 | 0.87 | -3.82 |
| Weighted Avg Shares Out | 27 | 22 | 20 | 15 |
| Weighted Avg Shares Out Dil | 27 | 22 | 21 | 15 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $1 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$58 | -$10 | $18 | -$57 |
| % Margin | -523.3% | -52.3% | 45.7% | -9,624.3% |